Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by mjn797979on Jul 08, 2020 12:19pm
45 Views
Post# 31239827

RE:RE:RE:GUD and ATE.....

RE:RE:RE:GUD and ATE.....Ill start by saying my biggest mistake was making GUD a big holding in my portfolio, but thats my fault.
Im starting to question my investment here for sure, its dead money and I am down holding this since 2016. 
I keep referring to that moment when the acquisition was made. They had all this money, there was anticipation for an acquisition, it happened and should have resulted in more interest in this company but the opposite occurred.
Their last results were bad, stock is down considerably since.

They don't share much in terms of guidance, might happen once they complete acquisition but clearly the market is currently not liking this story.

They bought back shares under the NCIB and the price today is lower than the average share price they bought back. 

I hope things can start looking more positive and I say this after being a shareholder for a few years. 



Bullboard Posts